vimarsana.com
Home
Live Updates
Dr Devoe on Safety and Efficacy Data for ELI-002 7P in KRAS+
Dr Devoe on Safety and Efficacy Data for ELI-002 7P in KRAS+
Dr Devoe on Safety and Efficacy Data for ELI-002 7P in KRAS+, MRD+ PDAC and CRC
Craig E. Devoe, MD, MS, discusses data for ELI-002 7P in patients with MRD-positive pancreatic and colorectal cancers after locoregional therapy.
Related Keywords
Craige Devoe ,
,
Oncology Service ,
Rj Zuckerberg Cancer Center ,
Division Of Medical Oncology ,
Long Island Jewish Medical Center ,
Shore University Hospital ,
Medical Oncology ,
Zuckerberg Cancer Center ,
Hematology Oncology Service ,
North Shore University ,